1.Merlotti D, Gennari L, Dotta F, Lauro D, Nuti R. Mechanisms of impaired bone strength in type 1 and 2 diabetes. NutrMetabCardiovascDis 2010;20:683-90.
2.Yaturu S. Diabetesandskeletalhealth. J Diabetes 2009;1:246-54.
3.Räkel A, Sheehy O, Rahme E, LeLorier J. Osteoporosisamongpatientswithtype 1 andtype 2 diabetes. DiabetesMetab 2008;34:193-205.
4.Brown SA, Sharless JL. Osteoporosis: An Under-appreciatedComplication of Diabetes. AmericanDiabetesAssociation Web Page. ClinicalDiabetes 2004;22:10-20.
5.Vestergaard P. Discrepancies in bone mineral densityandfracture risk in patientswithtype 1 andtype 2 diabetes--a meta-analysis. OsteoporosInt 2007;18:427-44.
6.Isidro ML, Ruano B. Bone disease in diabetes. CurrDiabetesRev 2010;6:144-55.
7.Issa C, Zantout MS, Azar ST. Osteoporosis in men withdiabetesmellitus. J Osteoporos 2011;2011:651867.
8.de Paula FJ, Horowitz MC, Rosen CJ. Novelinsightsintotherelationshipbetweendiabetesandosteoporosis. DiabetesMetabResRev 2010;26:622-30.
9.Saito M, Marumo K. Collagencross-links as a determinant of bone quality: a possibleexplanationfor bone fragility in aging, osteoporosis, anddiabetesmellitus. OsteoporosInt 2010;21:195-214.
10.Iwamoto J, Sato Y, Takeda T, Matsumoto H. Bone qualityand vitamin K2 in type 2 diabetes: review of preclinicalandclinicalstudies. NutrRev 2011;69:162-7.
11.Vashishth D, Gibson GJ, Khoury JI, Schaffler MB, Kimura J, Fyhrie DP. Influence of nonenzymaticglycation on biomechanicalproperties of cortical bone. Bone 2001;28:195-201.
12.Schwartz AV, Garnero P, Hillier TA, Sellmeyer DE, Strotmeyer ES, Feingold KR et al. Health, Aging, and Body CompositionStudy. Pentosidineandincreasedfracture risk in olderadultswithtype 2 diabetes. J ClinEndocrinolMetab 2009;94:2380-6.
13.Yamaguchi T, Sugimoto T. Bone metabolismandfracture risk in type 2 diabetesmellitus. Endocr J 2011;58:613-24.
14.Neumann T, Sämann A, Lodes S, Kästner B, Franke S, Kiehntopf M et al. Glycaemiccontrol is positivelyassociatedwithprevalentfractures but not with bone mineral density in patientswithType 1 diabetes. DiabetMed 2011;28:872-5.
15.McCabe LR. Understandingthepathologyandmechanisms of type I diabetic bone loss. J Cell Biochem 2007;102:1343-57.
16.Hamilton EJ, Rakic V, Davis WA, Paul Chubb SA, Kamber N, Prince RL et al. A five-yearprospectivestudy of bone mineral density in men andwomenwithdiabetes: TheFremantleDiabetesStudy. ActaDiabetol 2011;Epub ahead of print).
17.vanDaele PL, Stolk RP, Burger H, Algra D, Grobbee DE, Hofman A et al. Bone density in non-insulin-dependentdiabetesmellitus. The Rotterdam Study. AnnInternMed 1995;122:409-14.
18.Schwartz AV, Sellmeyer DE, Ensrud KE, Cauley JA, Tabor HK, Schreiner PJ et al; Study of OsteoporoticFeaturesResearchGroup. Olderwomenwithdiabeteshave an increased risk of fracture: a prospectivestudy. J ClinEndocrinolMetab 2001;86:32-8.
19.Melton LJ 3rd, Leibson CL, Achenbach SJ, Therneau TM, Khosla S. Fracture risk in type 2 diabetes: update of a population-basedstudy. J Bone MinerRes 2008;23:1334-42.
20.De Laet C, Kanis JA, Odén A, Johanson H, Johnell O, Delmas P et al. Body massindex as a predictor of fracture risk: a meta-analysis. OsteoporosisInt 2005;16:1330-8.
21.Viégas M, Costa C, Lopes A, Griz L, Medeiro MA, Bandeira F. Prevalence of osteoporosisandvertebralfractures in postmenopausalwomenwithtype 2 diabetesmellitusandtheirrelationshipwithduration of thediseaseandchroniccomplications. J DiabetesComplications 2011;25:216-21.
22.Li H, Cui R, Cai H, Wu G, Lv Z, Sheng C et al. Theeffect of thiazolidinediones on bone mineral density in Chineseolderpatientswithtype 2 diabetes. J Bone MinerMetab 2010;28:77-81.